An Act relative to insulin access

This bill caps out-of-pocket insulin costs at $100 per 30-day supply for all patients, regardless of insulin type or quantity needed. It directly affects insulin users, drug manufacturers, and insurers by requiring them to limit patient costs. Drug companies must offer free 30-day insulin supplies to eligible individuals urgently needing insulin (with less than a 7-day supply) who meet income limits (≤400% federal poverty level) and lack private drug coverage. The law also mandates manufacturers to establish accessible application processes for this assistance program within 14 days.